Pulmonx (STU:4NI) Total Stockholders Equity : €71.84 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Pulmonx Total Stockholders Equity?

Pulmonx's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €71.84 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pulmonx's Book Value per Share for the quarter that ended in Mar. 2025 was €1.79. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pulmonx's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.73.

Pulmonx Total Stockholders Equity Historical Data

The historical data trend for Pulmonx's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulmonx Total Stockholders Equity Chart

Pulmonx Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

185.88

171.02

145.38

108.50

81.95

Pulmonx Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															101.66	94.00	84.63	81.95	71.84

Pulmonx (STU:4NI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pulmonx's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(71.842	-	0)	/	40.247
	=	1.79

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pulmonx's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.236	+	44.442)	/	71.842
	=	0.73

Pulmonx Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pulmonx's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulmonx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulmonx Corp (STU:4NI) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LUNG:USA 4NI:Germany

Address

700 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.pulmonx.com

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Pulmonx Headlines

No Headlines